Boost your knowledge on R&D of COVID-19 vaccine candidates and possible treatments
The first Flanders Vaccine COVID-19 webinar series was a big success, thanks to high-level presentations of our Belgian top experts* and interesting questions from the participants.
In both sessions, Flanders Vaccine members from academia and industry shared up-to-date scientific information on the special road to a vaccine or treatment to control the COVID-19 pandemic.
Tools for collaboration
We want to stimulate innovation in the development of immunotherapeutics and vaccines by catalyzing new public-private partnerships between knowledge centers, health organisations, pharmaceutical and biotech companies. This should reinforce the leading position in the development and improvement of vaccines for both prevention as well as therapy of a wide range of diseases.
Boost your knowledge
Research, development and production of vaccines and immunotherapeutics is a complex process involving a multidisciplinary field of expertise. An overview of institutions offering courses and training programmes in relevant aspects related to vaccinology can be found here.
Flanders Vaccine supports the development of immunotherapeutics and vaccines for both prophylactic and therapeutic targets in humans and animals by facilitating the exchange of know-how and complementary innovative technologies between academia and industry. The Flanders Vaccine platform can be seen as an integrated tool that gives rise to more and better partnerships.